Product search
Filter
Search results
Tris NaCl EDTA Buffer with heparin neutralisation, pH 7.85
For testing direct FXa inhibitors, especially with BIOPHEN Heparin LRT (ref. 221011 / 221013 / 221015), BIOPHEN Heparin 3 (ref. 221003), BIOPHEN Heparin 6 (ref. 221006) or BIOPHEN DiXaI (ref. 221030). This buffer totally neutralizes heparin present in the assay sample and renders a measurement totally specific for DiXaI.
Human Antithrombin Neutralisation Set
Neutralisation of antithrombin in human plasma.
vWF deficient plasma, congenital (Type 3), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 3) deficient plasma.
vWF deficient plasma, congenital (Type 2B), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2B) deficient plasma.
vWF Deficient Plasma, congenital (Type 2A), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2A) deficient plasma.
Prekallikrein EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
vWF Deficient Plasma, congenital (Type 1), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 1) deficient plasma.
NAPTT Reagent Kit
Liquid "ready for use", containing synthetic phospholipid blend. This kit is intended for use in the European Pharmacopoeia (EP) method for the detection of activated coagulation factors in therapeutic products. Also, the NAPTT reagent alone can be used in the NAPTT test for detecting contact activation and hypercoagulability (For Research Use Only).
Tris buffer - progressive AT - Anti Xa, pH 7.85
Dilution buffer for progressive antithrombin activity assay, using a variant protocol for BIOPHEN®Antithrombin kit (ref. 221102/221105).
Tris buffer - progressive AT - Anti IIa, pH 8.40
Dilution buffer for progressive antithrombin activity using an anti IIa method, and a variant protocol of BIOPHEN®AT (Anti IIa) kit (ref. 221122), performed in the absence of heparin.